Home Applications 022244 Application 022244
Type NDA
Sponsor EISAI INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LUSEDRA FOSPROPOFOL DISODIUM SOLUTION;INTRAVENOUS 1050MG/30ML (35MG/ML) No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022244-001 LUSEDRA FOSPROPOFOL DISODIUM 1050MG/30ML (35MG/ML) SOLUTION / INTRAVENOUS 2008-12-12
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N022244-001 LUSEDRA 1050MG/30ML (35MG/ML) SOLUTION / INTRAVENOUS 2008-12-12 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022244-001 LUSEDRA 1050MG/30ML (35MG/ML) SOLUTION / INTRAVENOUS 2008-12-12 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022244-001 LUSEDRA 1050MG/30ML (35MG/ML) SOLUTION / INTRAVENOUS 2008-12-12 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N022244-001 LUSEDRA 1050MG/30ML (35MG/ML) SOLUTION / INTRAVENOUS 2008-12-12 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product ea99ee380514…2023-01-26 05:58 UTC 2023-01 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022244-001 6204257 2022-07-01 U-945 Drug substance, Drug product cb3db0bc1861…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.